NO20012817L - Fenetyl-5-brompyridyltiourea (PBT) og dihydroalkoksybenzyloksopyrimidin (DABO) derivater som utoverspermicidal aktivitet - Google Patents
Fenetyl-5-brompyridyltiourea (PBT) og dihydroalkoksybenzyloksopyrimidin (DABO) derivater som utoverspermicidal aktivitetInfo
- Publication number
- NO20012817L NO20012817L NO20012817A NO20012817A NO20012817L NO 20012817 L NO20012817 L NO 20012817L NO 20012817 A NO20012817 A NO 20012817A NO 20012817 A NO20012817 A NO 20012817A NO 20012817 L NO20012817 L NO 20012817L
- Authority
- NO
- Norway
- Prior art keywords
- activity
- bromopyridylthiourea
- dabo
- pbt
- phenethyl
- Prior art date
Links
- FTSGLGFFJMUGDU-UHFFFAOYSA-N 1-(5-bromopyridin-2-yl)-1-(2-phenylethyl)thiourea Chemical compound C=1C=C(Br)C=NC=1N(C(=S)N)CCC1=CC=CC=C1 FTSGLGFFJMUGDU-UHFFFAOYSA-N 0.000 title abstract 4
- 230000001150 spermicidal effect Effects 0.000 abstract 2
- 239000012871 anti-fungal composition Substances 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003100 immobilizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pregnancy & Childbirth (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/224,677 US6136335A (en) | 1998-12-31 | 1998-12-31 | Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity |
PCT/US1999/031160 WO2000039095A2 (en) | 1998-12-31 | 1999-12-29 | Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20012817D0 NO20012817D0 (no) | 2001-06-07 |
NO20012817L true NO20012817L (no) | 2001-08-29 |
Family
ID=22841684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20012817A NO20012817L (no) | 1998-12-31 | 2001-06-07 | Fenetyl-5-brompyridyltiourea (PBT) og dihydroalkoksybenzyloksopyrimidin (DABO) derivater som utoverspermicidal aktivitet |
Country Status (15)
Country | Link |
---|---|
US (2) | US6136335A (ja) |
EP (2) | EP1140848B1 (ja) |
JP (1) | JP2002533444A (ja) |
KR (1) | KR20010082772A (ja) |
CN (1) | CN1371367A (ja) |
AT (1) | ATE306475T1 (ja) |
AU (1) | AU2396800A (ja) |
BR (1) | BR9916620A (ja) |
CA (1) | CA2362492A1 (ja) |
DE (1) | DE69927710T2 (ja) |
HU (1) | HUP0104904A2 (ja) |
IL (1) | IL143508A0 (ja) |
MX (1) | MXPA01006746A (ja) |
NO (1) | NO20012817L (ja) |
WO (1) | WO2000039095A2 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1305313B1 (it) * | 1998-07-17 | 2001-05-04 | Colla Paolo | 3,4 - diidro- 6- benzil-4-oxopirimidine sostituite e relativo processodi produzione e impiego nella terapia delle infezioni da hiv-1. |
US6136335A (en) * | 1998-12-31 | 2000-10-24 | Hughes Institute | Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity |
US7064114B2 (en) * | 1999-03-19 | 2006-06-20 | Parker Hughes Institute | Gel-microemulsion formulations |
WO2002040021A2 (en) * | 2000-11-17 | 2002-05-23 | Idenix (Cayman) Limited | Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
SE0100733D0 (sv) | 2001-03-05 | 2001-03-05 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
SE0102867D0 (sv) | 2001-08-28 | 2001-08-28 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
US6929945B2 (en) * | 2002-12-09 | 2005-08-16 | Advanced Fluidix Laboratories Llc | Male fertility assay method and device |
TW200600492A (en) | 2004-05-18 | 2006-01-01 | Achillion Pharmaceuticals Inc | Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
EP2247603B1 (en) | 2008-02-12 | 2016-09-28 | Dow AgroSciences LLC | Pesticidal compositions |
CN101628996B (zh) * | 2008-07-18 | 2012-05-30 | 绿神(北京)乳胶业有限公司 | 一种乳胶避孕套的制备方法 |
MA34951B1 (fr) | 2011-02-09 | 2014-03-01 | Dow Agrosciences Llc | Compositions pesticides et procedes associes |
UA115126C2 (uk) | 2011-07-12 | 2017-09-25 | ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі | Пестицидні композиції і способи, які їх стосуються |
CN103193771B (zh) * | 2013-03-29 | 2015-08-05 | 中国人民解放军军事医学科学院生物工程研究所 | 链状酰胺类ccr5受体抑制剂的药物新用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR950006713B1 (ko) | 1988-03-31 | 1995-06-21 | 미쓰비시 가세이 가부시끼가이샤 | 6-치환 비환식 피리미딘뉴클레오시드 유도체 및 그 유도체를 유효성분으로 하는 항 비루스제 |
US5686428A (en) * | 1989-04-07 | 1997-11-11 | Aktiebolaget Astra | Pharmaceutical composition |
HU205917B (en) * | 1989-09-29 | 1992-07-28 | Mitsubishi Chem Ind | Process for producing 6-substituted pyrimidine derivatives and antiviral pharmaceutical compositions containing them as active components |
US5503978A (en) * | 1990-06-11 | 1996-04-02 | University Research Corporation | Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase |
IL102548A (en) * | 1991-08-02 | 1998-08-16 | Medivir Ab | Use of painting derivatives in the preparation of drugs for VIH inhibition and treatment of SDIA and new compounds |
US5593993A (en) * | 1991-08-02 | 1997-01-14 | Medivir Ab | Method for inhibition of HIV related viruses |
JPH0725770A (ja) * | 1993-07-09 | 1995-01-27 | Mitsubishi Chem Corp | 経皮吸収性抗ウイルス剤 |
AU687440B2 (en) * | 1993-08-24 | 1998-02-26 | Medivir Ab | Compounds and methods for inhibition of HIV and related viruses |
US5998411A (en) * | 1998-03-17 | 1999-12-07 | Hughes Institute | Heterocyclic nonnucleoside inhibitors of reverse transcriptase |
IT1305313B1 (it) * | 1998-07-17 | 2001-05-04 | Colla Paolo | 3,4 - diidro- 6- benzil-4-oxopirimidine sostituite e relativo processodi produzione e impiego nella terapia delle infezioni da hiv-1. |
US6136335A (en) * | 1998-12-31 | 2000-10-24 | Hughes Institute | Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity |
-
1998
- 1998-12-31 US US09/224,677 patent/US6136335A/en not_active Expired - Fee Related
-
1999
- 1999-12-29 JP JP2000591006A patent/JP2002533444A/ja not_active Withdrawn
- 1999-12-29 IL IL14350899A patent/IL143508A0/xx unknown
- 1999-12-29 BR BR9916620-8A patent/BR9916620A/pt not_active Application Discontinuation
- 1999-12-29 EP EP99967737A patent/EP1140848B1/en not_active Expired - Lifetime
- 1999-12-29 KR KR1020017008222A patent/KR20010082772A/ko not_active Application Discontinuation
- 1999-12-29 CN CN99815250A patent/CN1371367A/zh active Pending
- 1999-12-29 EP EP04030236A patent/EP1557197A1/en not_active Withdrawn
- 1999-12-29 AT AT99967737T patent/ATE306475T1/de not_active IP Right Cessation
- 1999-12-29 CA CA002362492A patent/CA2362492A1/en not_active Abandoned
- 1999-12-29 WO PCT/US1999/031160 patent/WO2000039095A2/en active IP Right Grant
- 1999-12-29 DE DE69927710T patent/DE69927710T2/de not_active Expired - Fee Related
- 1999-12-29 MX MXPA01006746A patent/MXPA01006746A/es unknown
- 1999-12-29 HU HU0104904A patent/HUP0104904A2/hu unknown
- 1999-12-29 AU AU23968/00A patent/AU2396800A/en not_active Abandoned
-
2000
- 2000-03-20 US US09/533,267 patent/US6376504B1/en not_active Expired - Fee Related
-
2001
- 2001-06-07 NO NO20012817A patent/NO20012817L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1140848B1 (en) | 2005-10-12 |
WO2000039095A3 (en) | 2000-11-09 |
US6376504B1 (en) | 2002-04-23 |
WO2000039095A2 (en) | 2000-07-06 |
EP1140848A2 (en) | 2001-10-10 |
ATE306475T1 (de) | 2005-10-15 |
EP1557197A1 (en) | 2005-07-27 |
KR20010082772A (ko) | 2001-08-30 |
HUP0104904A2 (hu) | 2002-04-29 |
DE69927710T2 (de) | 2006-07-20 |
US6136335A (en) | 2000-10-24 |
JP2002533444A (ja) | 2002-10-08 |
CN1371367A (zh) | 2002-09-25 |
AU2396800A (en) | 2000-07-31 |
NO20012817D0 (no) | 2001-06-07 |
CA2362492A1 (en) | 2000-07-06 |
IL143508A0 (en) | 2002-04-21 |
BR9916620A (pt) | 2001-09-25 |
MXPA01006746A (es) | 2002-04-24 |
WO2000039095B1 (en) | 2001-06-21 |
DE69927710D1 (de) | 2006-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20012817L (no) | Fenetyl-5-brompyridyltiourea (PBT) og dihydroalkoksybenzyloksopyrimidin (DABO) derivater som utoverspermicidal aktivitet | |
BR0116402A (pt) | Derivados de tetrahidropiridina, sua preparação e sua utilização como inibidores de proliferação celular | |
PT650476E (pt) | Agente vasodilatador periferico que contem derivados n-acilados de 4-amino-piperidina como ingredientes activos | |
TR200602857T1 (tr) | Bitki zararlılarının kontrol edilmesi için bileşimler. | |
DK1187601T3 (da) | Hidtil ukendt præparat og administrationsform som omfatter en syrelabil protonpumpeinhibitor | |
BR9806296A (pt) | Derivados de ácido sulfìnico e sua preparação e uso | |
DK350688A (da) | Middel til heling af celler og vaev | |
NO331183B1 (no) | Farmasoytisk preparat omfattende en halokondrinanalog eller et farmasoytisk salt derav og en farmasoytisk akseptabel baerer | |
ES2056071T3 (es) | Triazolinonas substituidas. | |
ES2032514T3 (es) | Derivados heterociclicos, su preparacion, y agentes radiosensibilizantes y agentes antivirales que los comprenden como su componente activo. | |
DE69116550T2 (de) | Steroid-sulfatase-inhibitoren | |
PT1001930E (pt) | Derivados de n-hidroxiformamida como inibidores de metaloproteinases de matriz | |
NO20013675L (no) | 2,3,4,5-tetrahydro-1H-[1,4)benzodiazepin-3-hydroksamsyre som matriks-metalloproteinase-inhibitorer | |
ES2066060T3 (es) | Solucion humectada para impresion litografica. | |
CA2289787A1 (en) | Fungicidal mixtures | |
DK0842165T3 (da) | Thiazolidin-4-carboxylsyrederivater som cytobeskyttende midler | |
RU94038042A (ru) | Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент | |
ES2039218T3 (es) | Procedimiento para preparar 1-hidroxi-2-piridonas. | |
FI955524A (fi) | Kiinteinä liuoksina olevia valmisteita | |
BR0316500A (pt) | N-alquinil-2-(fenóxi substituìdas)alquilamidas e seu uso como fungicidas | |
ES2151070T3 (es) | Seleccion para inhibidores de la quitinasa. | |
IT8321497A0 (it) | Derivati dell'ossalodidinone-2n-arilato otticamente attivi, inibitori specifici e reversibili della monoammino ossidasi di tipo b e loro procedimento di preparazione. | |
AR240858A2 (es) | Una composicion fungicida | |
TR199801574T2 (xx) | Mizolastin ihtiva eden yava� i�letme farmakolojik form�lleri. | |
ATE45064T1 (de) | Sterilisierende und desinfizierende gepufferte glutaraldehydzusammensetzungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |